BNP PARIBAS FINANCIAL MARKETS - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$373,782,000
+131.1%
10,850
+12.1%
0.00%
Q2 2020$161,719,000
-58.6%
9,678
-64.3%
0.00%
-100.0%
Q1 2020$390,724,000
+86.9%
27,096
+333.9%
0.00%
Q4 2019$209,020,000
+25.5%
6,245
-21.5%
0.00%
Q3 2019$166,536,000
+36.6%
7,953
+35.9%
0.00%
Q2 2019$121,880,000
-45.8%
5,854
-41.8%
0.00%
Q1 2019$224,774,000
+835.0%
10,057
+900.7%
0.00%
Q4 2018$24,040,000
-64.4%
1,005
-59.3%
0.00%
Q3 2018$67,436,000
+10.3%
2,472
+8.8%
0.00%
Q2 2018$61,121,000
-74.4%
2,273
-69.7%
0.00%
Q1 2018$238,502,000
-13.4%
7,493
+2.9%
0.00%
Q4 2017$275,292,000
+152.5%
7,279
+65.5%
0.00%
Q3 2017$109,026,000
+32.2%
4,398
+9.6%
0.00%
Q2 2017$82,487,000
+741.7%
4,012
+789.6%
0.00%
Q1 2017$9,800,000
-73.4%
451
-75.0%
0.00%
Q4 2016$36,830,000
+13.0%
1,801
-17.1%
0.00%
Q3 2016$32,580,000
+173.2%
2,172
+97.1%
0.00%
Q2 2016$11,924,000
+17435.3%
1,102
+21940.0%
0.00%
Q1 2016$68,000
-99.8%
5
-99.8%
0.00%
Q4 2015$42,102,000
-19.5%
2,282
+10.5%
0.00%
Q3 2015$52,286,0002,0650.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders